ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan
· Delayed Price · Currency is TWD 27.05
-0.05 (-0.18%)
Apr 24, 2025, 1:30 PM CST
ShareHope Medicine Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 4,326 | 3,873 | 4,137 | 3,850 | 4,099 | Upgrade
|
| Revenue Growth (YoY) | 11.68% | -6.38% | 7.46% | -6.07% | 31.21% | Upgrade
|
| Cost of Revenue | 3,611 | 3,147 | 3,153 | 3,016 | 2,919 | Upgrade
|
| Gross Profit | 714.4 | 726.38 | 983.91 | 833.96 | 1,180 | Upgrade
|
| Selling, General & Admin | 727.54 | 697.17 | 718 | 664.41 | 706.89 | Upgrade
|
| Research & Development | 11.82 | 12.3 | 16.4 | - | - | Upgrade
|
| Other Operating Expenses | -78.51 | -80.88 | -77.84 | -69.2 | -43.59 | Upgrade
|
| Operating Expenses | 671.79 | 631.69 | 654.53 | 579.7 | 666.2 | Upgrade
|
| Operating Income | 42.61 | 94.69 | 329.38 | 254.26 | 513.72 | Upgrade
|
| Interest Expense | -57.39 | -53.64 | -38.12 | -20.1 | -14.52 | Upgrade
|
| Interest & Investment Income | 57.61 | 10.26 | 6.06 | 5.1 | 7.93 | Upgrade
|
| Earnings From Equity Investments | 0.44 | -1.85 | -0.4 | -0.22 | -2.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.81 | 0.9 | 10.95 | -4.17 | -0.85 | Upgrade
|
| Other Non Operating Income (Expenses) | 24.33 | 24.41 | 70.85 | 15.63 | 17.58 | Upgrade
|
| EBT Excluding Unusual Items | 70.4 | 74.77 | 378.7 | 250.5 | 521.65 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.28 | 8.89 | 2.96 | 38.59 | -41.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | 135.64 | 23.91 | 9.13 | 3.71 | 0.84 | Upgrade
|
| Asset Writedown | -41.65 | 0.92 | -51.47 | -25.65 | - | Upgrade
|
| Other Unusual Items | 0.24 | 0.5 | 0.6 | 0.48 | -2.2 | Upgrade
|
| Pretax Income | 173.91 | 108.98 | 339.94 | 267.63 | 479.1 | Upgrade
|
| Income Tax Expense | 51.51 | 53.72 | 95.83 | 74.2 | 118.02 | Upgrade
|
| Earnings From Continuing Operations | 122.4 | 55.27 | 244.11 | 193.43 | 361.08 | Upgrade
|
| Minority Interest in Earnings | 77.7 | 69.29 | 49.84 | 39.24 | -113.37 | Upgrade
|
| Net Income | 200.1 | 124.56 | 293.95 | 232.66 | 247.71 | Upgrade
|
| Net Income to Common | 200.1 | 124.56 | 293.95 | 232.66 | 247.71 | Upgrade
|
| Net Income Growth | 60.65% | -57.63% | 26.34% | -6.08% | 27.00% | Upgrade
|
| Shares Outstanding (Basic) | 131 | 131 | 131 | 131 | 130 | Upgrade
|
| Shares Outstanding (Diluted) | 132 | 132 | 132 | 132 | 135 | Upgrade
|
| Shares Change (YoY) | 0.05% | -0.26% | -0.28% | -1.83% | 0.03% | Upgrade
|
| EPS (Basic) | 1.53 | 0.95 | 2.24 | 1.77 | 1.90 | Upgrade
|
| EPS (Diluted) | 1.52 | 0.95 | 2.23 | 1.76 | 1.85 | Upgrade
|
| EPS Growth | 60.00% | -57.41% | 26.73% | -4.75% | 26.64% | Upgrade
|
| Free Cash Flow | 183.6 | 6.83 | -623.51 | 222.59 | 359.85 | Upgrade
|
| Free Cash Flow Per Share | 1.39 | 0.05 | -4.72 | 1.68 | 2.67 | Upgrade
|
| Dividend Per Share | - | 0.385 | 0.458 | 0.436 | 0.415 | Upgrade
|
| Dividend Growth | - | -16.01% | 5.00% | 5.01% | - | Upgrade
|
| Gross Margin | 16.52% | 18.75% | 23.78% | 21.66% | 28.79% | Upgrade
|
| Operating Margin | 0.98% | 2.44% | 7.96% | 6.60% | 12.53% | Upgrade
|
| Profit Margin | 4.63% | 3.22% | 7.11% | 6.04% | 6.04% | Upgrade
|
| Free Cash Flow Margin | 4.24% | 0.18% | -15.07% | 5.78% | 8.78% | Upgrade
|
| EBITDA | 214.83 | 276.12 | 499.51 | 435.05 | 654.92 | Upgrade
|
| EBITDA Margin | 4.97% | 7.13% | 12.07% | 11.30% | 15.98% | Upgrade
|
| D&A For EBITDA | 172.22 | 181.43 | 170.13 | 180.79 | 141.2 | Upgrade
|
| EBIT | 42.61 | 94.69 | 329.38 | 254.26 | 513.72 | Upgrade
|
| EBIT Margin | 0.98% | 2.44% | 7.96% | 6.60% | 12.53% | Upgrade
|
| Effective Tax Rate | 29.62% | 49.29% | 28.19% | 27.73% | 24.63% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.